Udi Gilboa
Co-founder & Chairman
Claimed by owner Nasus Pharma
Former names:
Powder-based Intra-nasal Products
Nasus Pharma
www.prnewswire.co.uk
•
Mar 17, 2021
Safety of Taffix reaffirmed
www.dailymail.co.uk
•
Mar 16, 2021
Spanish regulators BAN £51 nasal spray that may cut risk from Covid
www.calcalistech.com
•
Oct 14, 2020
Nasal spray to stop spread of Covid-19? Israeli pharma company puts its product to the test
www.jpost.com
•
Sep 30, 2020
https://www.jpost.com/health-science/israeli-pharma-pioneer-introduces-taffix-antiviral-nose-powder-644001
www.hospimedica.com
•
Jul 9, 2020
Innovative Nasal Powder Inhaler Blocks More than 99% of SARS-CoV-2 Viruses from Reaching Nasal Mucosa in Studies
www.globenewswire.com
•
Jul 7, 2020
Nasus Pharma Announces Data Demonstrating Efficacy of TaffiX® Intranasal Antiviral Protection Against SARS-CoV-2
About
Nasus Pharma is developing a number of intranasal powder products aimed at assisting patients in several acute emergency situations (such as opioid overdose and anaphylactic shock) based on its microsphere technology.
Nasus's portfolio comprises a number of programs including intranasal naloxone, intranasal epinephrine, and a number of preclinical proof-of-concept programs.
Nasus's portfolio comprises a number of programs including intranasal naloxone, intranasal epinephrine, and a number of preclinical proof-of-concept programs.
Primary Sector
Life Sciences & HealthTech
Products
Intranasal Naloxone (NS -001), Taffix, Intranasal Epinephrine (NS 002)
Geographic markets
United States, Israel, Europe
Funding
Total Funding
Undisclosed
Last Funding
Undisclosed
Funding Stage
Total Rounds
0
Investors
0
News
(6)
www.prnewswire.co.uk
•
Mar 17, 2021
Safety of Taffix reaffirmed
www.dailymail.co.uk
•
Mar 16, 2021
Spanish regulators BAN £51 nasal spray that may cut risk from Covid
www.calcalistech.com
•
Oct 14, 2020
Nasal spray to stop spread of Covid-19? Israeli pharma company puts its product to the test
www.jpost.com
•
Sep 30, 2020
https://www.jpost.com/health-science/israeli-pharma-pioneer-introduces-taffix-antiviral-nose-powder-644001
www.hospimedica.com
•
Jul 9, 2020
Innovative Nasal Powder Inhaler Blocks More than 99% of SARS-CoV-2 Viruses from Reaching Nasal Mucosa in Studies
www.globenewswire.com
•
Jul 7, 2020
Nasus Pharma Announces Data Demonstrating Efficacy of TaffiX® Intranasal Antiviral Protection Against SARS-CoV-2
The Team
(5)
UG
DDM
Dr. Dalia Meggido
Co-founder, CEO & Board Member
TL
Tair Lapidot
VP R&D and Clinical Development
IE
Iris Erez
Commercial And Marketing Director
CA
Carolina Abrutzky
Director of CMC
Connect with
What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300
Sending invitation...
Company Lifecycle
Media gallery
(2)
How does Taffix work?
Taffix Do You Believe in Christmas
Locations
Israel
Menachem Begin Road 48, Tel Aviv-Yafo, Israel
Locations
Israel
Menachem Begin Road 48, Tel Aviv-Yafo, Israel
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
- Get unlimited search results
- Save to custom lists - Smartlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,